Enhanced Detection of Early Hepatocellular Carcinoma by Serum SELDI-TOF Proteomic Signature Combined with Alpha-Fetoprotein Marker

BACKGROUND: Biomarkers for accurate diagnosis of early hepatocellular carcinoma (HCC) are limited in number and clinical validation. We applied SELDI-TOF-MS ProteinChip technology to identify serum profile for distinguishing HCC and liver cirrhosis (LC) and to compare the accuracy of SELDI-TOF-MS pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lei, Ho, David W. Y., Lee, Nikki P. Y., Sun, Stella, Lam, Brian, Wong, Kwong-Fai, Yi, Xin, Lau, George K., Ng, Eddy W. Y., Poon, Terence C. W., Lai, Paul B. S., Cai, Zongwei, Peng, Jirun, Leng, Xisheng, Poon, Ronnie T. P., Luk, John M.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Translational Research and Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924503/
https://www.ncbi.nlm.nih.gov/pubmed/20354800
http://dx.doi.org/10.1245/s10434-010-1038-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924503/
https://www.ncbi.nlm.nih.gov/pubmed/20354800
http://dx.doi.org/10.1245/s10434-010-1038-8

Ejemplares similares